VENTAS REIT INC (VTR)
Sector: Real Estate
Sector: Real Estate
VENTAS REIT INC - Executive Compensation
Executive Vice President, Outpatient Medical and Research, Ventas, Inc. President and CEO, Lillibridge Healthcare Services, Inc.
Executive Compensation
Peter J. Bulgarelli serves as the Executive Vice President of Outpatient Medical & Research at Ventas, Inc., and concurrently holds the positions of President and CEO at Lillibridge Healthcare Services, Inc., a subsidiary of Ventas. With an extensive background in healthcare real estate, Bulgarelli has been instrumental in driving the strategic direction and growth of Ventas' outpatient medical and research portfolio. His leadership has been pivotal in expanding Ventas' presence in the outpatient sector, which is a key component of the company's diversified healthcare real estate investments. Prior to joining Ventas, Bulgarelli held various leadership roles in the real estate and healthcare industries, where he developed a deep understanding of the unique challenges and opportunities within healthcare real estate. His expertise in leasing, asset management, and development has enabled him to effectively manage and grow Lillibridge Healthcare Services, enhancing its reputation as a leading provider of outpatient medical real estate solutions. Under his guidance, Lillibridge has successfully expanded its portfolio and strengthened its relationships with healthcare providers, ensuring high-quality, accessible medical facilities for communities across the United States. In his current role at Ventas, Bulgarelli is responsible for overseeing the company's outpatient medical and research assets, which include a diverse range of properties such as medical office buildings, ambulatory care centers, and research facilities. His strategic vision and operational expertise have been crucial in positioning Ventas as a leader in the healthcare real estate market. Bulgarelli's commitment to innovation and excellence continues to drive the company's success, as he works to identify new opportunities and enhance the value of Ventas' outpatient medical and research portfolio.